Matches in Wikidata for { <http://www.wikidata.org/entity/Q94087438> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q94087438 description "wetenschappelijk artikel" @default.
- Q94087438 description "наукова стаття" @default.
- Q94087438 name "P01.052 Updated results of the INTELLANCE 2/EORTC trial 1410 randomized phase II study on Depatux -M alone, Depatux-M in combination with temozolomide (TMZ) and either TMZ or lomustine (LOM) in recurrent EGFR amplified glioblastoma (NCT02343406)" @default.
- Q94087438 name "P01.052 Updated results of the INTELLANCE 2/EORTC trial 1410 randomized phase II study on Depatux -M alone, Depatux-M in combination with temozolomide (TMZ) and either TMZ or lomustine (LOM) in recurrent EGFR amplified glioblastoma (NCT02343406)" @default.
- Q94087438 type Item @default.
- Q94087438 label "P01.052 Updated results of the INTELLANCE 2/EORTC trial 1410 randomized phase II study on Depatux -M alone, Depatux-M in combination with temozolomide (TMZ) and either TMZ or lomustine (LOM) in recurrent EGFR amplified glioblastoma (NCT02343406)" @default.
- Q94087438 label "P01.052 Updated results of the INTELLANCE 2/EORTC trial 1410 randomized phase II study on Depatux -M alone, Depatux-M in combination with temozolomide (TMZ) and either TMZ or lomustine (LOM) in recurrent EGFR amplified glioblastoma (NCT02343406)" @default.
- Q94087438 prefLabel "P01.052 Updated results of the INTELLANCE 2/EORTC trial 1410 randomized phase II study on Depatux -M alone, Depatux-M in combination with temozolomide (TMZ) and either TMZ or lomustine (LOM) in recurrent EGFR amplified glioblastoma (NCT02343406)" @default.
- Q94087438 prefLabel "P01.052 Updated results of the INTELLANCE 2/EORTC trial 1410 randomized phase II study on Depatux -M alone, Depatux-M in combination with temozolomide (TMZ) and either TMZ or lomustine (LOM) in recurrent EGFR amplified glioblastoma (NCT02343406)" @default.
- Q94087438 P1433 Q94087438-41C3FF8F-6145-46AB-99DA-B4DFCADB233D @default.
- Q94087438 P1476 Q94087438-26548406-1952-45C8-8C4C-29D877E0DC19 @default.
- Q94087438 P2093 Q94087438-0E258E43-8C92-474C-B964-BF9B963187F6 @default.
- Q94087438 P2093 Q94087438-115FF0CB-DE75-40A9-9116-6F4B29835CD6 @default.
- Q94087438 P2093 Q94087438-2B965FCD-235C-45A3-8B1A-BD40E6834522 @default.
- Q94087438 P2093 Q94087438-9190DD01-B1DD-41D3-921F-ECBE4A5BE38F @default.
- Q94087438 P2093 Q94087438-95211706-463C-496B-8DFE-C7C21CD89FB6 @default.
- Q94087438 P2093 Q94087438-9F1EFA69-D137-41FB-821C-2C13F79EFD90 @default.
- Q94087438 P2093 Q94087438-AFB326A3-86BC-4180-BDE9-71007034ED90 @default.
- Q94087438 P2093 Q94087438-BB8A8975-2287-4D29-93D3-ED7196F1B14B @default.
- Q94087438 P2093 Q94087438-DC43D713-9532-4664-88A0-D734527AC70B @default.
- Q94087438 P2093 Q94087438-E8F55689-7DB8-4FBA-8071-A1F9419097E3 @default.
- Q94087438 P304 Q94087438-924FE123-BD23-4638-BE10-60515A4E5D39 @default.
- Q94087438 P31 Q94087438-5F5028C9-EB7F-43C2-9795-46763BDA264D @default.
- Q94087438 P356 Q94087438-63BB255D-1E4B-4764-8010-FB91F885990E @default.
- Q94087438 P433 Q94087438-25AE70DE-8B9B-4048-9A84-EDD20675DFA6 @default.
- Q94087438 P478 Q94087438-5353143F-0550-4FF0-9AD0-9083DC3592B6 @default.
- Q94087438 P577 Q94087438-650FF96B-AC76-4740-951D-EBB766F928FD @default.
- Q94087438 P921 Q94087438-2814E7FC-D71A-45C9-9E8C-C279B1B762AB @default.
- Q94087438 P921 Q94087438-3C420541-12E6-43DD-B920-D3F280F549E2 @default.
- Q94087438 P921 Q94087438-77F639D2-6118-4E7C-8605-ED9C5D9DB305 @default.
- Q94087438 P932 Q94087438-FA330FB0-742C-4ED7-899F-45BE49A3BFE5 @default.
- Q94087438 P356 NOY139.094 @default.
- Q94087438 P1433 Q15724471 @default.
- Q94087438 P1476 "P01.052 Updated results of the INTELLANCE 2/EORTC trial 1410 randomized phase II study on Depatux -M alone, Depatux-M in combination with temozolomide (TMZ) and either TMZ or lomustine (LOM) in recurrent EGFR amplified glioblastoma (NCT02343406)" @default.
- Q94087438 P2093 "A Walenkamp" @default.
- Q94087438 P2093 "J Looman" @default.
- Q94087438 P2093 "J Sepulvado" @default.
- Q94087438 P2093 "M Eoli" @default.
- Q94087438 P2093 "M Weller" @default.
- Q94087438 P2093 "M van den Bent" @default.
- Q94087438 P2093 "P Ansell" @default.
- Q94087438 P2093 "P French" @default.
- Q94087438 P2093 "T Gorlia" @default.
- Q94087438 P2093 "V Golfinopoulos" @default.
- Q94087438 P304 "iii241-iii241" @default.
- Q94087438 P31 Q13442814 @default.
- Q94087438 P356 "10.1093/NEUONC/NOY139.094" @default.
- Q94087438 P433 "Suppl 3" @default.
- Q94087438 P478 "20" @default.
- Q94087438 P577 "2018-09-19T00:00:00Z" @default.
- Q94087438 P921 Q282142 @default.
- Q94087438 P921 Q425088 @default.
- Q94087438 P921 Q42824440 @default.
- Q94087438 P932 "6144235" @default.